Lista de obras -

Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancer

artículo científico publicado en 2012

Adenoviruses with an αvβ integrin targeting moiety in the fiber shaft or the HI-loop increase tumor specificity without compromising antitumor efficacy in magnetic resonance imaging of colorectal cancer metastases

artículo científico publicado en 2010

An oncolytic adenovirus enhanced for toll-like receptor 9 stimulation increases antitumor immune responses and tumor clearance

artículo científico publicado en 2012

Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models

artículo científico publicado en 2009

Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus

artículo científico publicado en 2013

Calcium gluconate in phosphate buffered saline increases gene delivery with adenovirus type 5.

artículo científico publicado en 2010

Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

artículo científico publicado en 2015

Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus

artículo científico publicado en 2010

Electrochemical immunosensors in breast and ovarian cancer

artículo científico publicado en 2013

From monoclonal antibodies to chimeric antigen receptors for the treatment of human malignancies

artículo científico publicado en 2014

GMCSF-armed vaccinia virus induces an antitumor immune response

artículo científico publicado en 2014

Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir

artículo científico publicado en 2010

Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus

artículo científico publicado en 2012

Immunological effects of a tumor necrosis factor alpha-armed oncolytic adenovirus

artículo científico publicado en 2015

Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus

artículo científico publicado en 2011

In vivo and in vitro distribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compartments

artículo científico publicado en 2011

Inducible Caspase-9 Selectively Modulates the Toxicities of CD19-Specific Chimeric Antigen Receptor-Modified T Cells

artículo científico publicado en 2017

Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus

artículo científico publicado en 2011

Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors

artículo científico publicado en 2011

MUC1 in endometriosis and ovarian cancer

artículo científico publicado en 2006

Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures

artículo científico publicado en 2009

Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells

artículo científico publicado en 2016

Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients

artículo científico publicado en 2010

Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients

artículo científico publicado en 2013

Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients

artículo científico publicado en 2012

Progresses towards safe and efficient gene therapy vectors

artículo científico publicado en 2015

SPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic adenovirus and 131I

artículo científico publicado en 2012

Serotype chimeric and fiber-mutated adenovirus Ad5/19p-HIT for targeting renal cancer and untargeting the liver

artículo científico publicado en 2009

Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans

artículo científico publicado en 2014

Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1.

artículo científico publicado en 2010

Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF.

artículo científico publicado en 2010

Lista de obras de

Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancer

Adenoviruses with an αvβ integrin targeting moiety in the fiber shaft or the HI-loop increase tumor specificity without compromising antitumor efficacy in magnetic resonance imaging of colorectal cancer metastases

An oncolytic adenovirus enhanced for toll-like receptor 9 stimulation increases antitumor immune responses and tumor clearance

Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models

Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus

Calcium gluconate in phosphate buffered saline increases gene delivery with adenovirus type 5.

Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus

Electrochemical immunosensors in breast and ovarian cancer

From monoclonal antibodies to chimeric antigen receptors for the treatment of human malignancies

GMCSF-armed vaccinia virus induces an antitumor immune response

Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir

Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus

Immunological effects of a tumor necrosis factor alpha-armed oncolytic adenovirus

Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus

In vivo and in vitro distribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compartments

Inducible Caspase-9 Selectively Modulates the Toxicities of CD19-Specific Chimeric Antigen Receptor-Modified T Cells

Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus

Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors

MUC1 in endometriosis and ovarian cancer

Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures

Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells

Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients

Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients

Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients

Progresses towards safe and efficient gene therapy vectors

SPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic adenovirus and 131I

Serotype chimeric and fiber-mutated adenovirus Ad5/19p-HIT for targeting renal cancer and untargeting the liver

Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans

Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1.

Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF.